Enrique Carrazana, MD

Two investigational intranasal formulations of olanzapine containing the permeation enhancer dodecyl maltoside showed favorable pharmacokinetics and an acceptable safety profile in healthy adults.

While oral and intramuscular formulations of pharmacologic agents continue to be commonly used to treat acute agitation, novel agents with alternative routes of delivery are becoming available.